Sooin Hwang - 14 Feb 2022 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Role
Chief Business Officer
Signature
By: /s/ Sooin Hwang
Issuer symbol
VINC
Transactions as of
14 Feb 2022
Net transactions value
$0
Form type
4
Filing time
16 Feb 2022, 15:10:38 UTC
Previous filing
27 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VINC Stock Option (right to buy) Award $0 +34,000 $0.000000 34,000 14 Feb 2022 Common Stock 34,000 $6.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests over three years, with 1/3 of the shares vesting on December 23, 2022, and 1/36th of the shares vesting monthly thereafter.